Post Traumatic Headache

Size: px
Start display at page:

Download "Post Traumatic Headache"

Transcription

1 Post Traumatic Headache Alan G Finkel MD FAAN FAHS Contractor supporting the Defense and Veteran Brain Injury Center (DVBIC) Womack Army Medical Center, Ft Bragg, NC 20SEP2013

2 Disclosures With regards to this talk the speaker has no financial conflicts to Disclose During the course of this talk I will mention off label use of medications THE ARE NO APPROVED DRUGS FOR CHRONIC POST TRAUMATIC HEADACHE Other Affiliations President and CEO, The Carolina Headache Foundation, Chapel Hill, NC Chair, PTH Section, American Headache Society Director, Carolina Headache Institute, Chapel Hill, NC Professor, University of North Carolina The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of Defense or Veterans Affairs position, policy or decision unless so designated by other documentation. This research was funded by the Department of Defense, U.S. Army, Defense and Veterans Brain Injury Center, in part through a contract with The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects). 2

3 pdf#page=17 3

4 Finkel AG, Headache 2010; 50:

5 Growing Interest Source: PubMed accessed

6 Traumatic Brain Injury (TBI) 6

7 The Surge? 70 # of Publications # o f Publications 10 0 Source: PubMed accessed

8 5. Headache attributed to head and/or neck trauma 5.1 Acute post-traumatic headache 5.2 Chronic post-traumatic headache 5.3 Acute headache attributed to whiplash injury 5.4 Chronic headache attributed to whiplash injury 5.5 Headache attributed to traumatic intracranial haematoma 5.6 Headache attributed to other head and/or neck trauma 5.7 Post-craniotomy headache International Headache Society 2003/5 8

9 5.2.2 Chronic post-traumatic headache attributed to mild head injury A. Headache, no typical characteristics known, fulfilling criteria C and D B. Head trauma with all the following: 1. either no loss of consciousness, or loss of consciousness of <30 minutes duration 2. Glasgow Coma Scale (GCS) >13 3. symptoms and/or signs diagnostic of concussion C. Headache develops within 7 days after head trauma D. Headache persists for >3 months after head trauma International Headache Society 2003/5 9

10 Primary or secondary headache? Primary: no other causative disorder International Headache Society 2003/5 10

11 Primary or secondary headache? Secondary (i.e., caused by another disorder): new headache occurring in close temporal relation to another disorder that is a known cause of headache Worsening of a pre-existing headache disorder International Headache Society 2003/5 11

12 IS POST-TRAUMATIC HEADACHE (PTH) Case control (n = 46) MVC: 52%; mild: 88% DIFFERENT? CTT M w/o A Other PCS PTH 75% 21% 4% 48% natural 57% population 40% <12% (cluster <1% No cases of migraine with aura or cluster Criteria met by both groups Haas, DC, Chronic post-traumatic headaches classified and compared with natural headaches, Cephalalgia 1996; 16:

13 Natural History of PTH Walker study (n=109) with moderate or severe TBI at VA rehabilitation facilities; mostly car accidents Source: Walker 2005, Headache after moderate and severe TBI: A longitudinal analysis 13

14 Natural History of PTH Acute: 38% 6 months: 36% (16% delayed) 12 months: 35% (16% delayed) Source: Figure 1 from Walker

15 Natural History after Mod-Sev TBI Hoffman JM, Lucas S, Dikmen S, Braden CA, Brown AW, Brunner R, Diaz-Arrastia R, Walker WC, Watanabe TK, Bell KR. Natural history of headache after traumatic brain injury. J Neurotrauma Sep;28(9):

16 What is the Diagnosis of Headache after Head Injury? 16

17 What about mild TBI? Lucas S, Hoffman JM, Bell KR, Dikmen S. A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia Aug 6 17

18 Risk Factor - AGE Lucas S, et al. Cephalalgia Aug 6 18

19 Risk Factor - GENDER Lucas S, et al. Cephalalgia Aug 6 19

20 Headache Diagnosis after Mild TBI Lucas S, et al. Cephalalgia Aug 6 20

21 Migraine With and Without Aura At least 2 attacks Lasts 4 72 hours Characteristics (2/4) Unilateral Throbbing Moderate-severe intensity Pain worsened by exertion (>95%) Associated symptoms (1/2) Nausea or vomiting Photophobia & phonophobia ICHD Cephalalgia, Vol 24, Supp 1,

22 Migraine Is: A personal biology with extremely high prevalence Associated with Lower thresholds to light and sound. Trigeminovascular activation Dura Mater C fiber Nociceptors Inflammation CGRP NKA Substance P Prostaglandins Termination by triptans 5HT 1B/D receptor agonists NSAIDs 22

23 Migraine Is: A neurovascular disorder Cortical Spreading Depression leads to: Trigeminovascular activation Dura Mater C fiber Nociceptors Inflammation CGRP NKA Substance P Prostaglandins Termination by triptans 5HT 1B/D receptor agonists NSAIDs 23

24 Headache in Civilian Population Migraine Males: 6% Females: 18% Proportion with aura: ~30% Chronic daily headache 3-4% of adult population 50% have chronic migraine ~ % with continuous headache 24

25 Migraine Prevalence by Age and Sex Rescaled Women: Prevalence 18% Men: Prevalence 6-7% Source: Data analysis from study referenced in Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996 Jul;47(1):

26 Prolonged TNC Stimulation May Lead to Central Sensitization Over-stimulation of the TNC Repeated stimulations and activations may lead to chronicification Chronic Migraine More than 15 days of headache (US = 8 or more migraine days) Affects 4% of the population Is the main type of headache seen in headache clinics 26

27 GOALS OF PREVENTIVE TREATMENT Decrease attack frequency (by 50%), intensity and duration Improve responsiveness to acute R x Improve function and decrease disability 27

28 WHEN TO USE PREVENTIVE MANAGEMENT Migraine significantly interferes with patient s daily routine, despite acute R x Acute medications contraindicated, ineffective, intolerable AEs or overused Frequent headache ( 2 attacks per week) Uncommon migraine conditions Patient preference 28

29 PREVENTIVE MEDICATIONS: DRUG CLASSES First Line Anticonvulsants Topiramate Valproate Beta Blockers Metoprolol Propranolol Antidepressants Amitriptyline NSAIDs Naproxen Ibuprofen Complimentary Herbal Petacites Minerals Magnesium Vitamin Riboflavin/B2 Other CoQ10 29

30 Special Populations Youth and Adult Sports 30

31 Do athletes get headaches? 31

32 Sports and Headache General population = 1% (Rasmussen) Aerobic - cardio Type and extent of exercise Compression swimmers goggle tight hat band weightlifters headache trauma-triggered and post-traumatic 32

33 Post-traumatic Headache 3.b. Headache arising from mechanisms that occur during exertion - Trauma Not case controlled Resemble primary headache disorders TTH is the most common footballers migraine Cluster-like (case report) Worsening of a pre-existing primary headache Kernick DP, Goadsby PJ; Royal College of General Practitioners; British Association for the Study of Headache. Guidance for the management of headache in sport on behalf of The Royal College of General Practitioners and The British Association for the Study of Headache. Cephalalgia Jan;31(1):

34 Differential and Evaluation Rule out secondary cause MRI Arnold-Chiari malformations Exertional weight lifters SAH Arterial dissection Cardiac ischemia BP and ECG Blood screening including TSH and diabetes Consider: urinary catecholamines Kernick DP, Goadsby PJ; Royal College of General Practitioners; British Association for the Study of Headache. Guidance for the management of headache in sport on behalf of The Royal College of General Practitioners and The British Association for the Study of Headache. Cephalalgia Jan;31(1):

35 Treatment - Acute McCrory P, Heywood J, Ugoni A. Open label study of intranasal sumatriptan (Imigran) for footballer's headache. Br J Sports Med Aug;39(8):

36 Treatment - preventive no evidence base Amitriptyline: Tyler GS, McNeely HE, Dick ML. Treatment of post-traumatic headache with amitriptyline. Headache Jul;20(4):213-6 N = 23 Age (mean) = 35.2 Time from injury = 29 weeks (3 77) Injury type: Recreational (1); non-vehicular (2); vehicular (20) 13 /23 excellent response 36

37 Youth sports Is Universal 38 million Not including playground Risk factors Competition Male: Football Female: Soccer Female Prior concussion High school injuries > 90% report headache immediately after concussion most symptoms resolve within a week (83%). 1.5% symptoms > 1 month Professional level no specific reports? symptomatic 37

38 Headache prevalence after mild and moderate-severe TBI Blume HK, Vavilala MS, Jaffe KM, Koepsell TD, Wang J, Temkin N, Durbin D, Dorsch A, Rivara FP. Headache after pediatric traumatic brain injury: a cohort study. Pediatrics Jan;129(1):e

39 Does Age or Gender Determine Headache After TBI? Blume HK, Vavilala MS, Jaffe KM, Koepsell TD, Wang J, Temkin N, Durbin D, Dorsch A, Rivara FP. Headache after pediatric traumatic brain injury: a cohort study. Pediatrics Jan;129(1):e

40 Treatment of Youth Sports PTH Cognitive rest is controversial When is prescription medication indicated? Consensus recommendations Preventive Amitriptyline Topamax (duh?) Beta blockers Acute Triptans are not as effective in adolescents and post-adolescents NSAIDs?Baclofen Avoid opioids Behavioral changes should be addressed Biofeedback 40

41 41

42 42

43 Where are we now? Headache is a recognized sequelae of youth sports concussion RTP guidelines are not specific if headache is the only remaining symptom Is persistent headache: a cardinal sign? a predictive variable? a reason to remain out of play? a (new onset) PRIMARY headache? 43

44 Special Populations Military 44

45 Medical Encounters for Migraine Active Duty Population Source: Medical Surveillance Monthly Report (MSMR) Vol 19 No. 2 Feb

46 46

47 Hoge et al, Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq. N Engl J Med 2008;358:

48 Hoge et al, Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq. N Engl J Med 2008;358:

49 Post-Deployment Headache Headache / migraine is common during or following deployment Complicates the interpretation of posttraumatic headache data in military populations 49

50 Headache in recently deployed soldiers (all) Source: Theeler et al, Prevalence and Impact of Migraine Among U.S. Army Soldiers deployed in support of Operation Iraqi Freedom, Headache 2008; n=

51 Headache Type Source: Scher et al, Headache Disorders in Recently Deployed Soldiers With and Without Traumatic Brain Injury, AAN Annual Meeting April

52 Frequency Source: Scher et al (Finkel), Headache Disorders in Recently Deployed Soldiers With and Without Traumatic Brain Injury, AAN Annual Meeting April

53 What Kind of Headaches Do Soldiers Have After Mild TBI? 53

54 Headache Characteristics per SM All Blast Non-blast # of Headaches (mean, range) 2.2 (1 3) 2.4 (2 3) 2 (1 3) Continuous headache (n, %) 22 (88) 13 (92.9) 9 (81.8) Finkel et al, Headache

55 Headache Onset Continuous (22/25) vs Episodic %) Finkel et al, Headache

56 Density Finkel et al, Headache

57 Density: Continuous vs Episodic Finkel et al, Headache

58 Primary Headache Diagnosis (per SM) Headache Diagnosis (ICHD). N MIGRAINE (some had more than one migraine type) 15 Migraine with aura (1.2) 5 Chronic tension-type headache (2.3) 12 Chronic cluster headache (3.1.2) 3 Chronic paroxysmal hemicrania (3.3.2) 1 Chronic SUNA (A3.3.2) 1 Primary stabbing headache (4.1) 4 Hemicrania continua (4.7) 2 Finkel et al, Headache

59 Secondary Headache Diagnosis Headache attributed to low cerebrospinal fluid pressure (7.2) 1 Headache attributed to disorder of the neck (11.2) 1 Headache attributed to craniocervical dystonia (11.2.3) 1 Headache or facial pain attribute to temporomandibular joint 1 (TMJ) disorder (11.7) Headache attributed to other disorder of cranium, neck eye, ears, 1 nose, etc. (11.8) Symptomatic trigeminal neuralgia (13.1.2) 2 Supraorbital neuralgia (13.6) Finkel et al, Headache

60 Observations: Headaches Injuries were more than 2 years ago Patients can describe multiple headaches Headache onset can occur after one week Continuous Headaches all start in less than one week Headaches may be superficial ( outside ) and focal Continuous Headaches are Less severe More aching and more neck pain Can have migraine features Episodic Headaches May start after one week Can be diagnosed using primary classification Finkel AG, Yerry J, Scher A, Choi YS. Headaches in soldiers with mild traumatic brain injury: findings and phenomenologic descriptions. Headache Jun;52(6):

61 TREATING PTH Based upon Diagnosis (sic) 61

62 Differential and Evaluation Primary Headache Secondary Headache MRI Intracranial Hypotension Chiari Malformation (?) Diffuser Tensor Imaging (DTI) -? Sleep Study Neuro-optometry Cervicogenic 62

63 Amitriptyline? Patil VK, St Andre JR, Crisan E, Smith BM, Evans CT, Steiner ML, Pape TL. Prevalence and treatment of headaches in veterans with mild traumatic brain injury. Headache Jul-Aug;51(7):

64 A Valiant Attempt Erickson JC. Treatment outcomes of chronic post-traumatic headaches after mild head trauma in US soldiers: an observational study. Headache Jun;51(6):

65 A Losing Battle? Cohen SP, et al. Headaches during war: Analysis of presentation, treatment, and factors associated with outcome. Cephalalgia Oct 18 65

66 A Novel Drug: Prazosin 66

67 Pathophysiology and Treatment A Modest Proposal 67

68 Outside or Inside: Does this explain why mtbi results in persistent headache? 68

69 Intracranial origin of extracranial pain In this scenario, action potentials generated intracranially at the leptomeningeal pain fibers spread antidromically to collaterals that terminate outside the cranium, resulting in activation of neighboring somatic nociceptors through local release of proinflammatory neuropeptides in both the dura and the scalp. This concept would be consistent with extracranial perivascular edema observed in some patients undergoing amigraine attack (Graham and Wolff, 1938; Wolff et al., 1953). This scenario may explain the perception of imploding headache (i.e., perception of pain on the outside of the skull; Jakubowski et al., 2006) in migraine triggered by intracranial events, such as aura. Finally, the presence of CGRP fibers in calvarial sutures, endosteum, and periosteum in the present study may constitute a neural substrate for the perception of deformed, crushed, or broken skull during migraine. (my emphasis) Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol Jul 20;515(3):

70 Extracranial origin of intracranial pain In this scenario, action potentials generated at extracranial collaterals of meningeal pain fibers spread antidromically to collaterals that terminate inside the cranium, resulting in local release of proinflammatory neuropeptides and activation of neighboring meningeal nociceptors. This scenario may explain the induction of migraine headache by extracranial triggers, such as tenderness of scalp muscles, or minor head trauma affecting the periosteum. (emphasis mine) Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol Jul 20;515(3):

71 Central or Peripheral? Jakubowski M, et al. Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain Dec 5;125(3):

72 Central or Peripheral? Patients randomized on basis of: Exploding: INSIDE OUT Feels like the head is too small for the brain A feeling of something trying to escape from inside the head Imploding: OUTSIDE IN Like a vice Imploding description predicted a better outcome to Onabotulinum Toxin A treatment for Chronic Migraine Jakubowski M, et al. Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain Dec 5;125(3):

73 Onabotulinum Toxin A (OBA) for the Treatment of Chronic Post-Traumatic Headache in Service Members with a History of Mild Traumatic Brain Injury Yerry, Finkel, et al: Presented at the International Headache Congress, JUN2013 Boston, MA 73

74 Demographics (n = 64) Age (20 50) ns Gender (M:F) 63 : 1 ns Prior history of migraine (%) 7 (10.9) p = 0.045* 74

75 Conclusions for the Study Outcomes were not influenced by PTSD Headache Days per month Patients with non-continuous headache but daily headache did better if a second continuous headache was no present Outcomes WERE influenced by History of headache prior to injury (negative) Number of treatments Time between injury and first treatment with OBA Continuous Headache 75

76 TREATMENT The Bad News No completed treatment trials PTSD and other PCS Co-morbidity or concurrency The Good News Treating the primary phenomenology works (sometimes) Migraine type Formulary based including Chronic Migraine (?)Tension type Continuous headache? Focal or nummular types The outside and the inside The exploding and imploding 76

77 Finally: What is it? TBI vs PTSD mtbi vs MUS* Headache *MEDICALLY UNEXPLAINED (ABLE) SYMPTOMS 77

78 Conclusions Post Traumatic Headache is complex Different populations Primary and secondary headaches may coexist Classification remains a challenge Does the boo-boo matter? Migraine and Chronic Migraine are the most common types Will imaging show changes similar to non-traumatic migraine? The 7 Day Rule may require revision Do Headache Types Mature? Treatment is slowly improving Using drugs and treatments for Migraine and Chronic Migraine appear to have some promise 78

79 Thank you for your attention The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of Defense or Veterans Affairs position, policy or decision unless so designated by other documentation. 79

Mild Head Trauma and Chronic Headaches in Returning US Soldiers. Brett J. Theeler, MD; Jay C. Erickson, MD, PhD

Mild Head Trauma and Chronic Headaches in Returning US Soldiers. Brett J. Theeler, MD; Jay C. Erickson, MD, PhD Headache 2009 the Authors Journal compilation 2009 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2009.01345.x Published by Wiley Periodicals, Inc. Research Submission Mild Head Trauma

More information

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา 1 CONTENT 1 2 3 Chronic Daily Headache Medical Overused Headache Management Headaches are one of the most common symptoms List

More information

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical

More information

Neurological Findings & Symptoms Associated with Acute Combat related Concussion: Disclosures. Impact of Migraine and Other Co morbidities

Neurological Findings & Symptoms Associated with Acute Combat related Concussion: Disclosures. Impact of Migraine and Other Co morbidities Neurological Findings & Symptoms Associated with Acute Combat related Concussion: Impact of Migraine and Other Co morbidities COL Beverly R. Scott Madigan Healthcare System Disclosures The views expressed

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association CGRP Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests

More information

UCNS Course A Review of ICHD-3b

UCNS Course A Review of ICHD-3b UCNS Course A Review of ICHD-3b Andrew D. Hershey, M.D., Ph.D., FAHS Endowed Chair and Director of Neurology Director, Cincinnati Children s Headache Center Professor of Neurology and Pediatrics University

More information

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. In 1962, Bille published landmark epidemiologic survey of headache among 9,000 school

More information

Disclosures. Objectives 11/10/2017. Research funding: Consultant and advisory: NIDILRR Wadsworth Foundation. Allergan Amgen Lilly Teva

Disclosures. Objectives 11/10/2017. Research funding: Consultant and advisory: NIDILRR Wadsworth Foundation. Allergan Amgen Lilly Teva AHS Scottsdale Headache Symposium 2017 Long Term Management of Posttraumatic Headache Sylvia Lucas MD, PhD, FAHS Clinical Professor of Neurology & Neurological Surgery Adjunct, Rehabilitation Medicine

More information

David W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA

David W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA Headache Masters School 2013 in Asia Sunday March 24, 2013 Procedural Medicine Workshop Onabotulinumtoxin A: Evidence, Injection Technique, and Mechanism of Action David W. Dodick M.D. Professor Director

More information

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal

More information

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type. Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369

More information

Mark W. Green, MD, FAAN

Mark W. Green, MD, FAAN Mark W. Green, MD, FAAN Professor of Neurology, Anesthesiology, and Rehabilitation Medicine Director of Headache and Pain Medicine Icahn School of Medicine at Mt Sinai New York Pain-sensitive structures

More information

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily

More information

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache Measure Description Percentage of patients age 18 years old and older diagnosed with migraine headache whose migraine frequency is 4 migraine

More information

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline Scottish intercollegiate Guidelines Network SIGN November 2008. PETER FRAMPTON MSc MCOptom BAppSc (Optom)(AUS)

More information

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am

More information

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA Preventive treatment of migraine Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA No disclosures Disclosures Many preventive treatments for migraine are not FDA-approved

More information

Headache evaluation and management after concussion. Assistant Professor

Headache evaluation and management after concussion. Assistant Professor Headache evaluation and management after concussion Juliette Preston, M.D. Assistant Professor OHSU Headache Center OVERVIEW Introduction Definition Acute post-traumatic headache Red flags Persistent post-traumatic

More information

10/19/12. Post-Traumatic Headache. Lawrence J. Horn, MD Disclosures. Speakers Bureau: Allergan, Inc.

10/19/12. Post-Traumatic Headache. Lawrence J. Horn, MD Disclosures. Speakers Bureau: Allergan, Inc. 10/19/12 Post-Traumatic Headache Professor and Interim Chair, Department of PM&R Wayne State University School of Medicine Detroit, MI Medical Director Neuroscience Rehabilitation Institute of Michigan

More information

8/6/18. Patient Experience. effective management of Chronic Migraine and Occipital Neuralgia in the Post 9/11 Combat Veteran

8/6/18. Patient Experience. effective management of Chronic Migraine and Occipital Neuralgia in the Post 9/11 Combat Veteran 8//8 Patient Experience Validation of practice based evidence for effective management of Chronic Migraine and Occipital Neuralgia in the Post 9/ Combat Veteran Karen Williams,MSN, RN, FNP-BC Neurology/Headache

More information

Migraine Treatment What you need to know

Migraine Treatment What you need to know Migraine Treatment What you need to know DR NICOLE LIMBERG ST ANDREWS PLACE SPRING HILL www.migrainespecialist.com.au Migraine what is it? Primary neurobiological condition Waves of reduced brain activity

More information

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Childhood headache: Is it really difficult to manage? It shouldn t be... But it can be...

More information

Migraine much more than just a headache

Migraine much more than just a headache Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker

More information

Chronic Daily Headaches

Chronic Daily Headaches Chronic Daily Headaches ANWARUL HAQ, MD, MRCP(UK), FAHS DIRECTOR BAYLOR HEADACHE CENTER, DALLAS, TEXAS DISCLOSURES: None OBJECTIVES AT THE CONCLUSION OF THIS ACTIVITY, PARTICIPANTS WILL BE ABLE TO: define

More information

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache. OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory

More information

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau: Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants

More information

IT S ALL IN YOUR HEAD!

IT S ALL IN YOUR HEAD! IT S ALL IN YOUR HEAD! CARING FOR CONCUSSIONS IN YOUR COMMUNITY Stephen K Stacey, DO CPT, MC, USA OUTLINE Definition Epidemiology Diagnosis Evaluation Recovery Sequelae Prevention Resources for providers

More information

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect

More information

Management of headache

Management of headache Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener,

More information

Measure Components Numerator Statement

Measure Components Numerator Statement MEASURE #5: OVERUSE OF OPIOID CONTAINING MEDICATIONS FOR PRIMARY HEADACHE DISORDERS Headache For Quality Improvement Only. Not to be used for Public Reporting or Accountability Measure Description Percentage

More information

Concussion. Concussion is a disturbance of brain function caused by a direct or indirect force to the head.

Concussion. Concussion is a disturbance of brain function caused by a direct or indirect force to the head. Concussion Concussion is a disturbance of brain function caused by a direct or indirect force to the head. Disturbances of brain tissue is largely related to neurometabolic dysfunction rather then structural

More information

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network

More information

Classification and WHO ICD-10NA Codes

Classification and WHO ICD-10NA Codes Classification and WHO ICD-10NA Codes IHS WHO Diagnosis ICHD-II ICD-10NA [and aetiological ICD-10 code for secondary headache disorders] code code 1. [G43] Migraine 1.1 [G43.0] Migraine without aura 1.2

More information

Disclosures. Objectives 6/2/2017

Disclosures. Objectives 6/2/2017 Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures

More information

Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis

Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis Noboru Imai(Department of Neurology, Japanese Red Cross

More information

By Nathan Hall Associate Editor

By Nathan Hall Associate Editor By Nathan Hall Associate Editor 34 Practical Neurology March 2005 These new rules may change the definition of head pain, but some practitioners may find the new guidelines themselves to be a source of

More information

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES JENNIFER SHIN, PHARMD PGY2 AMBULATORY CARE PHARMACY RESIDENT COMMUNITYCARE HEALTH CENTERS PHARMACOTHERAPY ROUNDS OCTOBER 20, 2017

More information

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015 1 Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin Tour de France 2015: Mark Renshaw Yesterday at the end of the stage 17 I came down with a migraine before the final climb

More information

Managing Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital

Managing Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital Managing Headache in Acute Medicine Ben Lovell Consultant Physician in Acute Medicine University College London Hospital Some ED headache stats Arrive by ambulance 31% Median age 39 Worst ever headache

More information

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy HEADACHE: Benign or Severe Dr Gobinda Chandra Roy Associate Professor, Department of Medicine, Shaheed Suhrawardy Medical College and Hospital Outlines 1. Introduction 2. Classification of headache 3.

More information

ADVANCES IN MIGRAINE MANAGEMENT

ADVANCES IN MIGRAINE MANAGEMENT ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades

More information

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache Measure Description Percentage of patients age 18 years old and older with a diagnosis of primary headache

More information

Headache Pain Generators

Headache Pain Generators Objectives 1. Define the major categories of headache. 2. Take a history directed at characterizing a headache pattern in an individual patient and identify the cause or triggers of the headache. 3. Understand

More information

Headaches in the Pediatric Emergency Dept

Headaches in the Pediatric Emergency Dept Headaches in Children February 23, 2011 Jinny Tavee, MD Associate Professor Neuromuscular Center Cleveland Clinic Foundation Cleveland, OH 1 Headaches in the Pediatric Emergency Dept Burton Gutierrez Kan

More information

TRAUMATIC BRAIN INJURY

TRAUMATIC BRAIN INJURY Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences TRAUMATIC BRAIN INJURY GARY STOBBE, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES The University of Washington

More information

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

Overuse of barbiturate and opioid containing medications for primary headache disorders Description Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed

More information

Approved for public release; distribution unlimited

Approved for public release; distribution unlimited Award Number: W81XWH-10-1-1021 TITLE: Post-traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury PRINCIPAL INVESTIGATOR: Sutapa Ford, PhD CONTRACTING ORGANIZATION:

More information

ONZETRA XSAIL (sumatriptan) nasal powder

ONZETRA XSAIL (sumatriptan) nasal powder ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 1 2 3 4 5 6 Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 years Efficacy of BoNT type A (onabotulinumtoxina,

More information

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time

More information

How do we treat migraine? New SIGN Guidelines

How do we treat migraine? New SIGN Guidelines How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood

More information

HEADACHES THE RED FLAGS

HEADACHES THE RED FLAGS HEADACHES THE RED FLAGS FAYYAZ AHMED CONSULTANT NEUROLOGIST HON. SENIOR LECTURER HULL YORK MEDICAL SCHOOL SECONDARY VS PRIMARY HEADACHES COMMON SECONDARY HEADACHES UNCOMMON BUT SERIOUS SECONDARY HEADACHES

More information

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES 1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International

More information

PREVALENCE BY HEADACHE TYPE

PREVALENCE BY HEADACHE TYPE CLINICAL CLUES AND CLINICAL RULES: PRIMARY VS SECONDARY HEADACHE * Based on a presentation by David W. Dodick, MD ABSTRACT Headache is a common condition, accounting for many specialist office visits annually.

More information

MIGRAINE ASSOCIATION OF IRELAND

MIGRAINE ASSOCIATION OF IRELAND MIGRAINE ASSOCIATION OF IRELAND HEADACHE IN MEN: THE FACTS This leaflet was composed by Paolo Rossi M.D., Ph.D. of the European Headache Alliance to mark European Migraine Day of Action 2014. Why a leaflet

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association CGRP Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests

More information

Characteristics of post-traumatic headaches in children following mild traumatic brain injury and their response to treatment: a prospective cohort

Characteristics of post-traumatic headaches in children following mild traumatic brain injury and their response to treatment: a prospective cohort DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY ORIGINAL ARTICLE Characteristics of post-traumatic headaches in children following mild traumatic brain injury and their response to treatment: a prospective cohort

More information

25/09/2018 HEADACHE. Dr Nick Pendleton

25/09/2018 HEADACHE. Dr Nick Pendleton HEADACHE Dr Nick Pendleton September 2018 1 Small Group Work Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache

More information

Headache A Practical Approach

Headache A Practical Approach Headache A Practical Approach Integrated Pain Symposium December 1, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache and Pain Development Teams Disclosures:

More information

Headaches in Pregnancy Before, During, and After

Headaches in Pregnancy Before, During, and After Headaches in Pregnancy Before, During, and After Robert Kaniecki, MD Director, UPMC Headache Center Assistant Professor of Neurology University of Pittsburgh Headaches and Pregnancy Pre-pregnancy counseling

More information

Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran

Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran Environ Health Prev Med (2014) 19:422 428 DOI 10.1007/s12199-014-0409-3 REGULAR ARTICLE Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran Saeid

More information

A prospective study of prevalence and characterization of headache following mild traumatic brain injury

A prospective study of prevalence and characterization of headache following mild traumatic brain injury Original Article A prospective study of prevalence and characterization of headache following mild traumatic brain injury Cephalalgia 2014, Vol 34(2) 93 102! International Headache Society 2013 Reprints

More information

HEADACHE. Dr Nick Pendleton. September Headache

HEADACHE. Dr Nick Pendleton. September Headache HEADACHE Dr Nick Pendleton September 2017 Headache Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache Raised ICP

More information

with susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine

with susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine Emerg Radiol (2012) 19:565 569 DOI 10.1007/s10140-012-1051-2 CASE REPORT Susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine Christopher Miller

More information

Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017

Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017 Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017 SAH v benign thunderclap headaches Other pathologies not apparent on CT Severe primary headaches: management

More information

Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children September 2018

Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children September 2018 Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children September 2018 Nothing to Disclose CDC Guidelines- Objective Question-

More information

Controlling Migraine Pain

Controlling Migraine Pain Migraine Stats Controlling Migraine Pain Alan Zacharias, M.D. Associated Neurologists, Boulder Community Health 303-622-3365 Women 15% Men 5% Usually starts in 2 nd and 3 rd Decade Major Impact on days

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Aimovig) Reference Number: CP.PHAR.128 Effective Date: 07.10.18 Last Review Date: 08.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Army troops suffering from traumatic brain injury

Army troops suffering from traumatic brain injury Army troops suffering from traumatic brain injury Since October 2001, more than two million American troops have deployed to fight the Global War on Terror being fought in Iraq and Afghanistan. The War

More information

Update on Diagnosis and Management of Migraines

Update on Diagnosis and Management of Migraines Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish

More information

Effectiveness of Pharmacological Treatments in Imploding vs. Exploding Headaches

Effectiveness of Pharmacological Treatments in Imploding vs. Exploding Headaches Effectiveness of Pharmacological Treatments in Imploding vs. Exploding Headaches Item Type Thesis Authors Hunt, Megan Publisher The University of Arizona. Rights Copyright is held by the author. Digital

More information

Headache Syndrome. Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL

Headache Syndrome. Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL Headache Syndrome Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL What is a headache? A headache or cephalgia is defined as pain anywhere in the region of head or neck Where does

More information

HEADACHE PATHOPHYSIOLOGY

HEADACHE PATHOPHYSIOLOGY HEADACHE PATHOPHYSIOLOGY Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research and Treatment

More information

Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont

Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont Controversy One: Headache and Disability Robert Shapiro, MD, PhD University of Vermont Southern Headache Society Orlando, FL, Sept 21, 2013 Disclosures Consulting within the past 12 months: Transcept Pharmaceuticals

More information

ACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli

ACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli The European Headache School 2012 ACUTE TREATMENT FOR MIGRAINE Cristina Tassorelli Headache Science Centre, IRCCS Neurological Institute C. Mondino Foundation - Pavia University Centre for Adaptive Disorders

More information

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification 28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification

More information

Strategies in Migraine Care

Strategies in Migraine Care Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives

More information

Concussion in Adventure Athletes Epidemiology and Current Guidelines. Aaron Provance, MD Medical Director

Concussion in Adventure Athletes Epidemiology and Current Guidelines. Aaron Provance, MD Medical Director Concussion in Adventure Athletes Epidemiology and Current Guidelines Aaron Provance, MD Medical Director No financial disclosures 2 Outline Epidemiology Good, Bad and Ugly Rest Injury prevention Long Term

More information

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. Faculty Disclosure Karen L. Bremer, MD Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. HEADACHE UPDATE Karen L. Bremer, MD November 10, 2017 karen.bremer@creighton.edu

More information

Migraine: Developing Drugs for Acute Treatment Guidance for Industry

Migraine: Developing Drugs for Acute Treatment Guidance for Industry Migraine: Developing Drugs for Acute Treatment Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) February 2018

More information

FINANCIAL DISCLOSURE. No relevant financial relationships

FINANCIAL DISCLOSURE. No relevant financial relationships Sleep and Headache Paul Mathew, MD, FAHS Director of Continuing Medical Education John R. Graham Headache Center Brigham & Women s Hospital Director of Headache Medicine Cambridge Health Alliance Harvard

More information

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond Chronic Headache In Pediatrics, Botox and Beyond Ken Mack MD PhD Mayo Clinic 2015 MFMER slide-1 Objectives Understand pediatric chronic headache presentations Review evidence for the treatment of chronic

More information

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when

More information

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc. RimabotulinumtoxinB NDC CODE(S) 10454-0710-XX Myobloc 2500 UNIT/0.5ML SOLN (SOLSTICE NEUROSCIENCES) 10454-0711-XX Myobloc 5000 UNIT/ML SOLN (SOLSTICE NEUROSCIENCES) 10454-0712-XX Myobloc 10000 UNIT/2ML

More information

PAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER

PAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction

More information

11/10/2017. THE BRIDGE Course Objectives. THE BRIDGE Course Objectives

11/10/2017. THE BRIDGE Course Objectives. THE BRIDGE Course Objectives THE BRIDGE Course Objectives Describe clinical characteristics associated with migraine diagnosis in adult and pediatric populations. Identify barriers and risk factors impacting the clinical course of

More information

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital Migraine Management Jane Melling Headache nurse Mater Misericordiae Hospital Migraine facts Among the most common disorders of the nervous system 3 rd most prevalent medical disorder on the planet (lancet

More information

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen

More information

Botox (Ona Botulinum Toxin Type A) For Treatment Of Chronic Daily Migraine Headaches (CDMH) In Veterans With Traumatic Brain Injury

Botox (Ona Botulinum Toxin Type A) For Treatment Of Chronic Daily Migraine Headaches (CDMH) In Veterans With Traumatic Brain Injury Botox (Ona Botulinum Toxin Type A) For Treatment Of Chronic Daily Migraine Headaches (CDMH) In Veterans With Traumatic Brain Injury DR. SALLY ZACHARIAH M.D., F.A.A.N. NEUROLOGIST/STROKE SPECIALIST BAY

More information

Director of Athletics

Director of Athletics 3341-8-1 Concussion Management Policy. Applicability Intercollegiate Athletics Responsible Unit Policy Administrator Intercollegiate Athletics/Director of Athletics Director of Athletics (A) Policy Purpose

More information

Mild Traumatic Brain Injury (mtbi): An Occupational Dilemma

Mild Traumatic Brain Injury (mtbi): An Occupational Dilemma Mild Traumatic Brain Injury (mtbi): An Occupational Dilemma William H. Cann, MD MPH Occupational Medicine Trainee Occupational Medicine Trainee University of Washington Disclosures None This presentation

More information

Pause for thought. Dr Jane Anderson Consultant Neurologist

Pause for thought. Dr Jane Anderson Consultant Neurologist Pause for thought Dr Jane Anderson Consultant Neurologist Which is the top cause of years lived with disability worldwide? 1. COPD 2. Low Back pain 3. Diabetes 4. Migraine with medication overuse headache

More information

PTSD and Other Invisible Wounds affecting our Service Members and Veterans. Alan Peterson, PhD, ABPP

PTSD and Other Invisible Wounds affecting our Service Members and Veterans. Alan Peterson, PhD, ABPP PTSD and Other Invisible Wounds affecting our Service Members and Veterans Alan Peterson, PhD, ABPP 1 Alan Peterson, PhD, ABPP Retired USAF Lt Col Clinical Health Psychologist Former Chair, Department

More information

Clinical Learning Days November 10, 2017

Clinical Learning Days November 10, 2017 Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion

More information

Sports Related Concussion. Joshua T. Williams, PT, DPT, OCS, SCS, CSCS

Sports Related Concussion. Joshua T. Williams, PT, DPT, OCS, SCS, CSCS Sports Related Concussion Joshua T. Williams, PT, DPT, OCS, SCS, CSCS Concussion & Traumatic Brain Injury Glasgow Coma Scale Minimal Mild Mod Severe? Sports concussion Severe GCS 8 Moderate GCS 9-12 Mild

More information

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT

More information

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018 Trigeminal Autonomic Cephalalgias Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018 Disclosures Honoraria from Allergan and Amgen for advisory board, Current Neurology and Neuroscience Reports

More information

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology Headache and Facial Pain Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology Introduction It is the most common neurologic complain The diagnosis usually

More information

Headache. Section 1. Migraine headache. Clinical presentation

Headache. Section 1. Migraine headache. Clinical presentation Section 1 Headache Migraine headache 1 Clinical presentation It is important to recognize just how significant a problem migraine headache is. It has been estimated that migraine affects 11% of the United

More information

ARxCH. Annual Review of Changes in Healthcare. Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines. Abstract

ARxCH. Annual Review of Changes in Healthcare. Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines. Abstract Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines Brian Schuler, PharmD Candidate 2018 1 1 University of Findlay College of Pharmacy Abstract Migraines are the third most prevalent

More information